RENAL PELVIS CANCER
Clinical trials for RENAL PELVIS CANCER explained in plain language.
Never miss a new study
Get alerted when new RENAL PELVIS CANCER trials appear
Sign up with your email to follow new studies for RENAL PELVIS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to shrink hard-to-treat cancers
Disease control OngoingThis early-phase study tests a new drug called LY4101174 in people with advanced or metastatic solid tumors that have come back or spread. The drug is designed to target and attack cancer cells while sparing healthy ones. The study will check if the drug is safe and what dose wor…
Matched conditions: RENAL PELVIS CANCER
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New cancer registry aims to unlock genetic secrets of urothelial tumors
Knowledge-focused OngoingThis study creates a registry of over 3,500 people, including those with and without urothelial cancer, to better understand the disease. Researchers will look at genetic markers in saliva and risk factors to find links to cancer risk and outcomes. The goal is to improve how we p…
Matched conditions: RENAL PELVIS CANCER
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 11:41 UTC